Hepatitis B Virus-Related Glomerulonephritis with Positive and Negative Serum HBsAg: Different Clinicopathologic Characteristics of Two Clinical Subtypes

References

• Zampino R, Boemio A, Sagnelli C, et al. Hepatitis B virus burden in developing countries. World j Gastroenterol. 2015;21(42):11941–11953. doi:10.3748/wjg.v21.i42.11941
   PubMed Web of Science ®Google Scholar
• Trépo C, Chan HL, Lok A. Hepatitis B virus infection. Lancet (London, England). 2014;384(9959):2053–2063. doi:10.1016/S0140-6736(14)60220-8
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global hepatitis report. Geneva: World Health Organization. 2017.
   Google Scholar
• World Health Organization. Hepatitis B; 2020. Newsroom/Fact sheets/detail.
   Google Scholar
• Cui Y, Jia J. Update on epidemiology of hepatitis B and C in China. J Gastroenterol Hepatol. 2013;28(Suppl 1):7–10. doi:10.1111/jgh.12220
   PubMed Web of Science ®Google Scholar
• Seto WK, Lo YR, Pawlotsky JM, Yuen MF. Chronic hepatitis B virus infection. Lancet (London, England). 2018;392(10161):2313–2324. doi:10.1016/S0140-6736(18)31865-8
   PubMed Web of Science ®Google Scholar
• Kupin WL, Viral-Associated GN. Hepatitis B and Other Viral Infections. Clin j Am Soc Nephrol. 2017;12(9):1529–1533. doi:10.2215/CJN.09180816
   PubMed Web of Science ®Google Scholar
• Raimondo G, Locarnini S, Pollicino T, Levrero M, Zoulim F, Lok AS. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019;71(2):397–408. doi:10.1016/j.jhep.2019.03.034
   PubMed Web of Science ®Google Scholar
• Li D, Gao G, Jiang H, Tang Z, Yu Y, Zang G. Hepatitis B virus-associated glomerulonephritis in HBsAg serological-negative patients. Eur J Gastroenterol Hepatol. 2015;27(1):65–69. doi:10.1097/MEG.0000000000000236
   PubMed Web of Science ®Google Scholar
• Shen Y, Chen X. Advice of hepatitis B virus (HBV) infection related glomerulonephropathy in Beijing symposium. Zhong Hua Nei Ke Za Zhi. 1990;9:519–521.
   Google Scholar
• Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604–612. doi:10.7326/0003-4819-150-9-200905050-00006
   PubMed Web of Science ®Google Scholar
• Trimarchi H, Barratt J, Cattran DC, et al. Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int. 2017;91(5):1014–1021. doi:10.1016/j.kint.2017.02.003
   PubMed Web of Science ®Google Scholar
• Hu R, Quan S, Wang Y, et al. Spectrum of biopsy proven renal diseases in Central China: a 10-year retrospective study based on 34,630 cases. Sci Rep. 2020;10(1):10994. doi:10.1038/s41598-020-67910-w
   PubMed Web of Science ®Google Scholar
• Zhang X, Liu S, Tang L, et al. Analysis of pathological data of renal biopsy at one single center in China from 1987 to 2012. Chin Med J. 2014;127(9):1715–1720.
   PubMed Web of Science ®Google Scholar
• Yang Y, Zhang Z, Zhuo L, Chen DP, Li WG. The spectrum of biopsy-proven glomerular disease in china: a systematic review. Chin Med J. 2018;131(6):731–735. doi:10.4103/0366-6999.226906
   PubMed Web of Science ®Google Scholar
• Nie P, Chen R, Luo M, et al. Clinical and pathological analysis of 4910 patients who received renal biopsies at a single center in Northeast China. Biomed Res Int. 2019;2019:6869179. doi:10.1155/2019/6869179
   PubMed Web of Science ®Google Scholar
• Zhu Q, Shao X, Chen S, et al. Epidemiological serosurvey of hepatitis B virus among children aged 1–14 years in Guangdong Province, China. Int j Infect Dis. 2018;71:25–29. doi:10.1016/j.ijid.2018.01.027
   PubMed Web of Science ®Google Scholar
• Shah AS, Amarapurkar DN. Spectrum of hepatitis B and renal involvement. Liver Int. 2018;38(1):23–32. doi:10.1111/liv.13498
   PubMed Web of Science ®Google Scholar
• Chang XJ, Sun C, Chen Y, et al. On-treatment monitoring of liver fibrosis with serum hepatitis B core-related antigen in chronic hepatitis B. World j Gastroenterol. 2019;25(32):4764–4778. doi:10.3748/wjg.v25.i32.4764
   PubMed Web of Science ®Google Scholar
• Lapalus M, Laouenan C, Cardoso AC, et al. Precore/Core promoter variants to predict significant fibrosis in both HBeAg positive and negative chronic hepatitis B. Liver Int. 2015;35(9):2082–2089. doi:10.1111/liv.12787
   PubMed Web of Science ®Google Scholar
• Lai KN, Ho RT, Tam JS, Lai FM. Detection of hepatitis B virus DNA and RNA in kidneys of HBV related glomerulonephritis. Kidney Int. 1996;50(6):1965–1977. doi:10.1038/ki.1996.519
   PubMed Web of Science ®Google Scholar
• Diao Z, Ding J, Yin C, Wang L, Liu W. Purified hepatitis B virus induces human mesangial cell proliferation and extracellular matrix expression in vitro. Virol J. 2013;10:300. doi:10.1186/1743-422X-10-300
   PubMed Web of Science ®Google Scholar
• Wang X, Wang L, Zhu N, Zhou Y, Gu LJ, Yuan WJ. Hepatitis B virus X protein modulates renal tubular epithelial cell-induced T-cell and macrophage responses. Immunol Cell Biol. 2016;94(3):266–273. doi:10.1038/icb.2015.85
   PubMed Web of Science ®Google Scholar
• Mizuno M, Suzuki Y, Ito Y. Complement regulation and kidney diseases: recent knowledge of the double-edged roles of complement activation in nephrology. Clin Exp Nephrol. 2018;22(1):3–14. doi:10.1007/s10157-017-1405-x
   PubMed Web of Science ®Google Scholar
• Nonaka M, Kimura A. Genomic view of the evolution of the complement system. Immunogenetics. 2006;58(9):701–713. doi:10.1007/s00251-006-0142-1
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang X, Zhang Y, Yuan W. Hepatitis B virus X protein and proinflammatory cytokines synergize to enhance TRAIL-induced apoptosis of renal tubular cells by upregulation of DR4. Int J Biochem Cell Biol. 2018;97:62–72. doi:10.1016/j.biocel.2018.02.006
   PubMed Web of Science ®Google Scholar
• Gupta A, Quigg RJ. Glomerular diseases associated with hepatitis B and C. Adv Chronic Kidney Dis. 2015;22(5):343–351. doi:10.1053/j.ackd.2015.06.003
   PubMed Web of Science ®Google Scholar
• Rovin BH, Caster DJ, Cattran DC, et al. Management and treatment of glomerular diseases (part 2): conclusions from a Kidney Disease: improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 2019;95(2):281–295. doi:10.1016/j.kint.2018.11.008
   PubMed Web of Science ®Google Scholar
• Liu Y, Shi C, Fan J, Wang B, Li G. Hepatitis B-related glomerulonephritis and optimization of treatment. Expert Rev Gastroenterol Hepatol. 2020;14(2):113–125. doi:10.1080/17474124.2020.1717948
   PubMed Web of Science ®Google Scholar